Esto se sabe sobre Opill, la nueva ‘minipíldora’ anticonceptivanews2023-05-13T09:00:31+00:00May 13th, 2023|The New York Times|
What to Know About the New Treatment for Hot Flashesnews2023-05-12T23:07:14+00:00May 12th, 2023|The New York Times|
FDA Approves New Drug to Treat Hot Flashesnews2023-05-12T20:09:58+00:00May 12th, 2023|The New York Times|
Big Pharma Is Avoiding Taxes, and Trump’s Tax Reforms Made It Worsenews2023-05-12T18:15:20+00:00May 12th, 2023|The New York Times|
Public Health Lessons Learned From the Coronavirus Pandemicnews2023-05-11T09:00:23+00:00May 11th, 2023|The New York Times|
Addiction Treatment Medicine Is Vastly Underprescribed, Especially by Race, Study Findsnews2023-05-10T21:49:51+00:00May 10th, 2023|The New York Times|
What an Over-the-Counter Birth Control Pill Could Mean for Younews2023-05-10T19:54:43+00:00May 10th, 2023|The New York Times|
F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risksnews2023-05-10T17:21:21+00:00May 10th, 2023|The New York Times|
As Covid Emergency Ends, U.S. Response Shifts to Peacetime Modenews2023-05-10T15:48:01+00:00May 10th, 2023|The New York Times|
F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pillnews2023-05-10T12:33:32+00:00May 10th, 2023|The New York Times|
